Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 18.66
-0.22 (-1.17%)
Oct 15, 2026, 1:55 PM CET
Celon Pharma Revenue
Revenue (ttm)
257.64M
Revenue Growth
+24.94%
P/S Ratio
3.95
Revenue / Employee
460.08K
Employees
560
Market Cap
1.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 102.25M | -12.69M | -11.04% |
| Dec 31, 2018 | 114.94M | 7.82M | 7.30% |
| Dec 31, 2017 | 107.12M | -21.66M | -16.82% |
| Dec 31, 2016 | 128.78M | 21.24M | 19.75% |
| Dec 31, 2015 | 107.54M | 9.44M | 9.62% |
| Dec 31, 2014 | 98.10M | 26.46M | 36.93% |
| Dec 31, 2013 | 71.64M | 31.53M | 78.61% |
| Dec 31, 2012 | 40.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 14.14B |
| Diagnostyka | 2.58B |
| Synektik Spólka Akcyjna | 932.97M |
| Centrum Medyczne ENEL-MED | 920.05M |
| Voxel | 640.61M |
| Mercator Medical | 625.18M |
| Ryvu Therapeutics | 83.94M |
| Medinice | 19.00K |
Celon Pharma News
- 4 weeks ago - Celon Pharma Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Celon Pharma Slides: Q2 2026 - Filings
- 4 months ago - Celon Pharma Quarterly report: Q1 2026 - Filings
- 4 months ago - Celon Pharma Slides: Q1 2026 - Filings
- 5 months ago - Celon Pharma Annual report: Q4 2025 - Filings
- 5 months ago - Celon Pharma Slides: Q4 2025 - Filings
- 10 months ago - Celon Pharma Quarterly report: Q3 2025 - Filings
- 10 months ago - Celon Pharma Slides: Q3 2025 - Filings